Accuray Inc. and RaySearch Laboratories AB announced they have signed a long-term collaboration agreement allowing Accuray to co-market and offer the RayCare oncology information system (OIS) which is currently in development at RaySearch. Under the contract, Accuray will have the opportunity to offer RayCare in several designated major radiation therapy markets, making available a fully-integrated solution with the TomoTherapy and CyberKnife System product portfolios.

21st Century Cures Act, H.R. 6, HR-6, HR 6, medical device innovation

The U.S. House of Representatives July 10 passed its version of the 21st Century Cures Act (H.R. 6), designed to improve the U.S. healthcare innovation infrastructure. It was approved in a bipartisan vote of 344-77. The bill calls for providing resources to researchers working on next-generation medical devices and therapies. The legislation is aimed at addressing concerns that U.S. healthcare innovation is lagging behind the rest of the world due to large amounts of time-consuming and expensive regulatory oversight requirements that some feel are stifling innovation and the ability of startup companies to bring new products to market.

The Centers for Medicare & Medicaid Services (CMS) and the American Medical Association (AMA) announced efforts to help physicians prepare for the nationwide switch from ICD-9 to ICD-10 ahead of the October 1 deadline. In response to requests from the provider community, CMS is releasing additional guidance that will allow for flexibility in the claims auditing and quality reporting process as the medical community gains experience using the new ICD-10 code set for medical diagnoses and inpatient hospital procedures.

Health data security and patient engagement are top priorities for the nation's hospitals, according to results of the 17th annual HealthCare's Most Wired Survey. The annual survey was released by the American Hospital Association's Health Forum and the College of Healthcare Information Management Executives (CHIME).

extended-field IMRT, cervical, endometrial cancer, duodenal toxicity, Pittsburgh

Women with cervical or endometrial cancer who require treatment to the para-aortic (PA) lymph nodes can safely receive extended-field intensity modulated radiation therapy (EF-IMRT) without increased risk of duodenal toxicity, according to a new study. Findings were published in the July-August 2015 issue of Practical Radiation Oncology (PRO), the American Society for Radiation Oncology’s (ASTRO’s) journal focused on the clinical practice of radiation oncology.

Lexmark  announced that it has received 510(k) Class II clearance from the U.S. Food and Drug Administration (FDA) for Lexmark NilRead, a Web-based, zero-footprint enterprise diagnostic viewer. The NilRead viewer is available in multiple configurations – core, clinical and interpretation – covering different workflows, ranging from the distribution of imaging studies and reports within the enterprise to full primary interpretation workflows in decoupled enterprise image management implementations.

Carestream is expanding into new imaging modalities — cone beam computed tomography (CBCT) and ultrasound — and key advances in these areas will be demonstrated at the Association for Medical Imaging Management (AHRA) conference July 19-22. For cone beam CT, which is currently undergoing patient studies, a conceptual scale model will be on display.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now